LAMISIL
LOE ApproachingNDAORALGRANULE
Approved
Sep 2007
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
2/8 — Basic
Drug data last refreshed 3d ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
LAMISIL is an oral granule antifungal treatment approved in 2007 for tinea pedis (athlete's foot), a common fungal infection of the feet. The product is a small-molecule oral formulation marketed by Novartis. Mechanism of action data is not publicly available in this dataset.
LOE Approaching
Product is in late-stage lifecycle with moderate competitive pressure (30/100), signaling smaller brand teams and defensive strategic focus rather than growth investment.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
Safety and Effectiveness of Giving Lamisil to HIV-Positive Subjects With Thrush Who Have Not Responded to Fluconazole Treatment
30 enrolled
Candidiasis, OralHIV Infections
Career Relevance
Working on LAMISIL represents a defensive, late-cycle career assignment focused on margin protection and managed care negotiations rather than growth or innovation. Roles are primarily commercial and operational, reflecting the product's mature market position and approaching loss of exclusivity.
Brand Manager
Worked on LAMISIL at Novartis? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.